The Roundtable: Our Thoughts About Model Based Drug Development

Author: David Turner

David Turner is a Principal Scientist at Certara's Simcyp division.

Recent Posts

PBPK Modeling of Supersaturating Drug Product Behavior

David Turner

The problem of supersaturating drug products might loosely be summed up as: “If you’re not part of the solution, you’re part of the precipitate!” Indeed, more than 60% of new drug candidates are poorly soluble1 which can severely limit their bioavailability. To ameliorate this issue, a common approach is formulating to create supersaturated solutions of […]

Read More
Topics: PBPK Modeling and Simulation
Learn More
LinkedIn